HighTower Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

HighTower Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,300	Closed	-$2K	–	3199
2021 Q2	$2K	Buy	+2,300	New	+$22.7K	﹤0.01%	3067

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

HighTower Advisors's SRTA Position: Q2 2025 in Review

HighTower Advisors sold out of Strata Critical Medical Inc (SRTA) in Q2 2025, closing a stake of 22,904 shares — an estimated $62.5K sold.

HighTower Advisors first reported a position in SRTA in Q2 2021 and held it in 16 quarters. The position peaked at $1.16M in Q2 2021. 126 funds tracked by Wall St. Rank hold SRTA as of Q2 2025.

HighTower Advisors reported no remaining Strata Critical Medical Inc position as of Q2 2025 after selling out during the quarter.
HighTower Advisors sold 22,904 Strata Critical Medical Inc shares in Q2 2025, an estimated $62.5K.
HighTower Advisors first reported a position in Strata Critical Medical Inc in Q2 2021 and held it in 16 quarters.
HighTower Advisors's Strata Critical Medical Inc position peaked at $1.16M in Q2 2021.
126 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2025.

Based on HighTower Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.